- Pineapple starts $100M INJ strategy with $8.9M buy
- 678,353 INJ tokens purchased to initiate the plan
- Strategy aims to support the Injective ecosystem
Pineapple, a prominent digital asset firm, has officially launched a $100 million strategy focused on Injective ($INJ), starting with a major purchase of 678,353 INJ tokens. This initial investment is valued at approximately $8.9 million and marks the beginning of a larger initiative aimed at supporting the Injective ecosystem.
The Injective Protocol is a decentralized finance ( DeFi ) platform designed for building high-speed, low-cost, and fully decentralized applications. Pineapple’s strategic move signals confidence in Injective’s long-term value and potential to drive innovation in the DeFi space.
What Pineapple’s $100M Strategy Means
Pineapple’s multi-million dollar commitment isn’t just a financial play — it’s a statement. With the crypto market recovering and DeFi regaining momentum, institutions like Pineapple are positioning themselves to back ecosystems they believe in. Injective, with its focus on derivatives, prediction markets, and cross-chain trading, fits that profile.
By kicking off with nearly $9 million in INJ, Pineapple shows it’s serious about supporting the network and potentially influencing its growth through long-term involvement.
Why This Matters for Injective and DeFi
This move could attract more attention and liquidity to Injective, especially if other firms follow suit. Large investments like these can fuel development, bring in new users, and reinforce trust in the project’s stability.
With a total of $100 million earmarked, this is just the beginning. It will be interesting to see how Pineapple deploys the rest of the capital and what partnerships or innovations emerge as a result.
